Teleman Dan Benjamin — SEC Form 4 filings

SEC reporting owner CIK 2122500. 4 Form 4 filings on record with FilingPulse; latest filed 2026-07-29.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2026-04-01 to 2026-07-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Nasus Pharma Ltd (NSRX)Chief Executive Officer, Director43 legs · 24,450 sh · $61,809

Form 4 filings — Teleman Dan Benjamin

FiledFormIssuerReported transactionsSource
2026-07-294Nasus Pharma Ltd (NSRX)Holdings only — no transactions reportedEDGAR
2026-06-224Nasus Pharma Ltd (NSRX)Purchase (P): 6,550 @ $3.10EDGAR
2026-04-224Nasus Pharma Ltd (NSRX)Purchase (P): 2,900 @ $3.76EDGAR
2026-04-014Nasus Pharma Ltd (NSRX)Purchase (P): 15,000 @ $2.04EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2122500 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →